Investor Lists

Genomics investors in Europe

Updated 7 November 2026

Firms observed backing a genomics company in Europe in the last two years, wherever the firm is based.

94investors on the list+1 this week
3,302cheques in 12 months+0% against the market
$27Mmedian round they joined+241% against the market median
93%wrote a cheque in 12 months
61%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1Y CombinatorDeploying nowAccelerator · United States6,412$3Mmedian roundOct 2026last seen
  2. 2Andreessen HorowitzDeploying nowVC firm · United States1,661$27Mmedian roundNov 2026last seen
  3. 3New Enterprise AssociatesDeploying nowVC firm · United States1,610$34Mmedian roundOct 2026last seen
  4. 4General CatalystDeploying nowVC firm · United States1,387$27Mmedian roundNov 2026last seen
  5. 5AccelDeploying nowVC firm · United States1,341$32Mmedian roundNov 2026last seen
  6. 6BpifranceDeploying nowGovernment · France1,151$4.5Mmedian roundOct 2026last seen
  7. 7Google VenturesDeploying nowCorporate VC · United States884$38Mmedian roundOct 2026last seen
  8. 8Innovate UKDeploying nowVC firm · United Kingdom704$1.2Mmedian roundOct 2026last seen
  9. 9Salesforce VenturesDeploying nowCorporate VC · United States649$26Mmedian roundNov 2026last seen
  10. 10Bain Capital VenturesDeploying nowVC firm · United States524$27Mmedian roundNov 2026last seen
  11. 11SeedcampDeploying nowVC firm · United Kingdom519$5Mmedian roundNov 2026last seen
  12. 12Kleiner PerkinsDeploying nowVC firm · United States398$40Mmedian roundNov 2026last seen
  13. 13RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  14. 14Temasek HoldingsDeploying nowVC firm · Singapore384$100Mmedian roundOct 2026last seen
  15. 15FirstMarkDeploying nowVC firm · United States319$20Mmedian roundOct 2026last seen
  16. 16HeadlineDeploying nowVC firm · United States307$15Mmedian roundOct 2026last seen
  17. 17NorthzoneDeploying nowVC firm · United Kingdom240$22Mmedian roundOct 2026last seen
  18. 18CDP Venture CapitalDeploying nowVC firm · Italy227$3.9Mmedian roundOct 2026last seen
  19. 19CreandumDeploying nowVC firm · Sweden224$20Mmedian roundOct 2026last seen
  20. 20Novo HoldingsDeploying nowVC firm · Denmark203$60Mmedian roundOct 2026last seen
  21. 21Rebel FundDeploying nowVC firm · United States201$2.4Mmedian roundOct 2026last seen
  22. 22Wellington PartnersDeploying nowVC firm · Germany180$33Mmedian roundJun 2026last seen
  23. 23Go CapitalDeploying nowVC firm · France167$6.5Mmedian roundSept 2026last seen
  24. 24Northstar VenturesDeploying nowVC firm · United Kingdom155$1.1Mmedian roundSept 2026last seen
  25. 25InvusDeploying nowPrivate equity · United States148$81Mmedian roundOct 2026last seen
69 more on this list

All 94 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about genomics investors in Europe

Who are the most active genomics investors in Europe?

By cheques observed, the most active are Y Combinator, Andreessen Horowitz, New Enterprise Associates, General Catalyst and Accel.

How many genomics investors in Europe are there?

94 are on record. 93% made an investment in the last 12 months and 61% have led a round.

Which stages do genomics investors in Europe back?

Of the rounds with a named stage in the last 12 months, mostly Seed (24%) and Series A (21%).

How big are the rounds genomics investors in Europe join?

The typical (median) round among the leading investors here is $26M.

Which sectors do genomics investors in Europe back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which genomics investors in Europe lead the most rounds?

Andreessen Horowitz (114 led), Accel (103 led) and General Catalyst (97 led).

Where are genomics investors in Europe based?

Among the most active, most are based in the United States (14), the United Kingdom (4) and France (2).

What have genomics investors in Europe invested in recently?

Recent rounds include Ocient (Series C, Nov 2026, with PSP Growth), Thinking Machines Lab (Other, Nov 2026, with Accel) and T-Therapeutics (Series B, Nov 2026, with British Business Bank).

Built from the rounds we watched, refreshed every night. How we count · Report a correction